XML 64 R30.htm IDEA: XBRL DOCUMENT
v3.24.0.1

SHAREHOLDERS EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 29, 2023
SHAREHOLDERS' EQUITY |
Summary of stock option activity | A summary of option activity under the 2006 Plan and 2008 Plan as of December 29, 2023 and changes during the fiscal years ended December 29, 2023, December 30, 2022 and December 31, 2021 is presented below. The intrinsic value of the fully-vested options is $3.7 million based on the Company’s closing stock price of $21.50 and the average exercise price of outstanding options on December 29, 2023.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- |
​ | ​ | ​ | ​ | Weighted- | ​ | Average |
​ | ​ | ​ | ​ | Average | ​ | Remaining |
​ | ​ | ​ | ​ | Exercise | ​ | Contractual |
​ |  | Options |  | Price |  | Term |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​ | (in years) | ​
Outstanding at December 30, 2022 |  | 816 | ​ | $ | 20.38 |  | 3.68 | ​
Granted |  | — | ​ |  | — |  | — | ​
Exercised |  | (19) | ​ |  | 9.77 |  | — | ​
Forfeited or expired |  | (10) | ​ |  | 19.05 |  | — | ​
Outstanding at December 29, 2023 |  | 787 | ​ | $ | 20.64 |  | 2.70 | ​
Vested and expected to vest at December 29, 2023 |  | 787 | ​ | $ | 20.64 |  | 2.70 | ​
Exercisable at December 29, 2023 |  | 787 | ​ | $ | 20.64 |  | 2.70 | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Average |
​ | ​ | ​ | ​ | Average | ​ | Remaining |
​ | ​ | ​ | ​ | Exercise | ​ | Contractual |
​ |  | Options |  | Price |  | Term |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​ | (in years) | ​
Outstanding at December 31, 2021 |  | 849 | ​ | $ | 19.89 |  | 4.68 | ​
Granted |  | — | ​ |  | — |  | — | ​
Exercised |  | (33) | ​ |  | 8.12 |  | — | ​
Forfeited or expired |  | — | ​ |  | — |  | — | ​
Outstanding at December 30, 2022 |  | 816 | ​ | $ | 20.38 |  | 3.68 | ​
Vested and expected to vest at December 30, 2022 |  | 816 | ​ | $ | 20.38 |  | 3.68 | ​
Exercisable at December 30, 2022 |  | 816 | ​ | $ | 20.38 |  | 3.68 | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- |
​ | ​ | ​ | ​ | Weighted- | ​ | Average |
​ | ​ | ​ | ​ | Average | ​ | Remaining |
​ | ​ | ​ | ​ | Exercise | ​ | Contractual |
​ |  | Options |  | Price |  | Term |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​ | (in years) | ​
Outstanding at January 1, 2021 |  | 1,003 | ​ | $ | 18.86 |  | 5.43 | ​
Granted |  | — | ​ |  | — |  | — | ​
Exercised |  | (150) | ​ |  | 12.86 |  | — | ​
Forfeited or expired |  | (4) | ​ |  | 24.33 |  | — | ​
Outstanding at December 31, 2021 |  | 849 | ​ | $ | 19.89 |  | 4.68 | ​
Vested and expected to vest at December 31, 2021 |  | 849 | ​ | $ | 19.89 |  | 4.68 | ​
Exercisable at December 31, 2021 |  | 849 | ​ | $ | 19.89 |  | 4.68 | ​
​ A summary of the status of the Company’s nonvested options and changes in nonvested options is presented below:
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- |
​ | ​ | ​ | ​ | Average |
​ | ​ | ​ | ​ | Grant-Date |
​ |  | Options |  | Fair Value |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​
Nonvested at December 30, 2022 |  | — | ​ | $ | — | ​
Granted |  | — | ​ |  | — | ​
Vested |  | — | ​ |  | — | ​
Forfeited |  | — | ​ |  | — | ​
Nonvested at December 29, 2023 |  | — | ​ |  | — | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​
​ | ​ | ​ | ​ | Average |
​ | ​ | ​ | ​ | Grant-Date |
​ |  | Options |  | Fair Value |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​
Nonvested at December 31, 2021 |  | — | ​ | $ | — | ​
Granted |  | — | ​ |  | — | ​
Vested |  | — | ​ |  | — | ​
Forfeited |  | — | ​ |  | — | ​
Nonvested at December 30, 2022 |  | — | ​ |  | — | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​
​ | ​ | ​ | ​ | Average |
​ | ​ | ​ | ​ | Grant-Date |
​ |  | Options |  | Fair Value |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​
Nonvested at January 1, 2021 |  | 52 | ​ | $ | 31.73 | ​
Granted |  | — | ​ |  | — | ​
Vested |  | (52) | ​ |  | 31.73 | ​
Forfeited |  | — | ​ |  | — | ​
Nonvested at December 31, 2021 |  | — | ​ |  | — | ​
Summary of restricted stock activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- |
​ | ​ | ​ | ​ | Average |
​ |  | Restricted Stock |  | Grant Date Fair Value |
​ | ​ | (in thousands) | ​ | ​ | ​ | ​
Outstanding at December 30, 2022 | ​ | 135 | ​ | $ | 34.07 |
Awarded | ​ | 154 | ​ | ​ | 18.04 | ​
Vested | ​ | (114) | ​ | ​ | 33.45 | ​
Forfeited | ​ | (4) | ​ | ​ | 17.83 | ​
Outstanding at December 29, 2023 | ​ | 171 | ​ | $ | 20.44 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding at December 31, 2021 | ​ | 110 | ​ | $ | 38.30 |
Awarded | ​ | 104 | ​ | ​ | 31.48 | ​
Vested | ​ | (74) | ​ | ​ | 36.55 | ​
Forfeited | ​ | (5) | ​ | ​ | 36.51 | ​
Outstanding at December 30, 2022 | ​ | 135 | ​ | $ | 34.07 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding at January 1, 2021 | ​ | 128 | ​ | $ | 33.21 |
Awarded | ​ | 63 |  | ​ | 41.02 | ​
Vested | ​ | (75) |  | ​ | 32.09 | ​
Forfeited | ​ | (6) |  | ​ | 36.69 | ​
Outstanding at December 31, 2021 | ​ | 110 | ​ | $ | 38.30 | ​
Summary of performance-based restricted stock unit activity | ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Performance-Based | ​ | Weighted-Average
​ |  | Restricted Stock Unit |  | Grant Date Fair Value
​ | ​ | (in thousands) | ​ | ​ | ​
Outstanding at December 30, 2022 | ​ | 66 | ​ | $ | 27.93
Awarded | ​ | 112 | ​ | ​ | 19.89
Released | ​ | (46) | ​ | ​ | 22.84
Forfeited | ​ | (2) | ​ | ​ | 21.67
Outstanding at December 29, 2023 | ​ | 130 | ​ | $ | 22.88
​ | ​ | ​ | ​ | ​ | ​
Outstanding at December 31, 2021 | ​ | 224 | ​ | $ | 31.31
Awarded | ​ | 186 | ​ | ​ | 38.82
Released | ​ | (278) | ​ | ​ | 40.99
Forfeited | ​ | (66) | ​ | ​ | 26.61
Outstanding at December 30, 2022 | ​ | 66 | ​ | $ | 27.93
​ | ​ | ​ | ​ | ​ | ​
Outstanding at January 1, 2021 | ​ | 379 | ​ | $ | 20.68
Awarded | ​ | 282 |  | ​ | 34.84
Released | ​ | (411) |  | ​ | 29.08
Forfeited | ​ | (26) |  | ​ | 29.93
Outstanding at December 31, 2021 | ​ | 224 | ​ | $ | 31.31
Summary of valuation assumptions | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2023 | ​ | ​ | 2022 | ​ | ​ | 2021 | ​
Weighted-average expected term (in years) | ​ |  | .5 | ​ | ​ |  | .5 | ​ | ​ |  | .5 | ​
Risk-Free interest Rate | ​ |  | 4.9 | % | ​ |  | 1.4 | % | ​ |  | 0.1 | %
Stock Price Volatility | ​ |  | 29.9 | % | ​ |  | 30.0 | % | ​ |  | 31.9 | %
Dividend yield | ​ |  | 0 | % | ​ |  | 0 | % | ​ |  | 0 | %
Fair Value | ​ | $ | 18.50 | ​ | ​ | $ | 31.11 | ​ | ​ | $ | 40.21 | ​

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration